PMI knows every aspect of the business. I look at them as an extension of my staff. They adapt to the way we work, they do a great job in market analysis, and they’ve helped us grow our programs.

Rebecca Rinehart
Director of Publications
American Psychiatric Association


Latest PMI News

For Immediate Release

ASH Chooses Wiley to Publish ASH Clinical News Starting in 2022
July 14, 2021

(WASHINGTON, July 14, 2021) – The American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatments of blood disorders, and global research and education leader Wiley today announced that, starting in January 2022, Wiley will publish ASH’s industry-leading newsmagazine, ASH Clinical News.

First published in October 2014, ASH Clinical News is a leading source of news and opinion content for the hematology and oncology community, reaching a global audience of more than 75,000 professionals each month in print and online. With more than 300 articles published per year, the magazine has an unparalleled impact on the industry, providing ASH members and hematology professionals alike with news and insights tailored to their needs, with a focus on the latest advances in the field.

“As the largest professional society for hematologists, ASH remains committed to delivering the most important and relevant information to help our members conquer blood diseases worldwide,” said ASH President Martin S. Tallman, MD. “ASH Clinical News is a key service to the profession, and we are delighted that Wiley will begin publication in 2022.”

“Science communication has never been more important – we see that among the 40+ newsmagazines we publish. We’re delighted to work with ASH on its flagship newsmagazine to bring world-class content to the hematology-oncology community and beyond,” said Jay Flynn, Wiley SVP & Chief Product Officer, Research.

Under an agreed strategy between ASH and Wiley, ASH Clinical News will accelerate its development as a multimedia brand. Across all formats, the publication will focus on maintaining its excellent reputation for high quality and timely content as the discipline evolves.

ASH’s current Publisher, AMC Media Group, will continue to publish ASH Clinical News through the end of 2021, and will remain the contact point for advertisers and sponsors for the remainder of 2021 issues. Wiley has selected Pharmaceutical Media Inc (PMI) to serve as its sales agent and contact point for advertisers and sponsors for ASH Clinical News issues in 2022 and beyond.

Media contacts
Geena De Rose, Wiley

Amanda Szabo, ASH, 202-552-4914

About the American Society of Hematology
The American Society of Hematology (ASH)( is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (, the most cited peer-reviewed publication in the field, and Blood Advances (, an online, peer-reviewed open-access journal.

About Wiley
Wiley (NYSE: JWA) is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at, Like us on Facebook, and follow us on Twitter and LinkedIn.

Oliver Cooper, CEO

Researcher Appoints Pharmaceutical Media, Inc. - Advertising Sales Representative

(NEW YORK and LONDON - August 17, 2020) - Researcher, the discovery platform for academics and scientists, and Pharmaceutical Media Inc, (PMI), a leading sales firm specializing in representing medical publishers and professional medical organizations, today announce a partnership that will enable PMI to add Researcher’s innovative advertising products to the suite of channels it offers to businesses in the life sciences and publishing sectors.

Researcher’s advertising enables marketers to reach the global audience of 1.7m scientists and academics who use Researcher’s apps and website to stay up to date with new and relevant scholarly papers that publish in their field. Marketers can create promoted content or creative-led campaigns directly into users’ feeds, using a level of granular targeting not available in any other channel - ensuring that marketing messages only reach the most relevant and most interested audience.

PMI is a full-service marketing and sales representation firm with a 49-year history of successful partnerships with leading medical publishers, professional medical organizations and life science publishing partners. PMI’s unique, client centered approach to advertising and special project sales optimizes value for partners, members and advertisers.

Researcher CEO Olly Cooper said: “We’re delighted to partner with PMI to expand our reach into the life sciences and medical society sector in the US. PMI has a fantastic track record of accelerating growth in these sectors for innovative and high-quality advertising products, and we’re excited about bringing our unique channel to a new market”.

PMI President Frank Cox said: “PMI is very excited to partner with Researcher due to the advanced technology of the platform designed as a discovery tool for researchers and medical professionals in fulfilment of their educational needs. Researcher is genuine breakthrough technology providing alerts to users on the latest breaking science within their predetermined area of interest. The app will allow advertisers to reach users when they are at their most engaged and in read and discovery mode".

PMI is in New York City and is a recognized leader in digital ad sales, ad operations and metric reporting and management.

For further information and press inquiries, contact: Frank Cox, President.


Researcher ( Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery. With over 15,000 journals across 10 research areas, just choose which journals you want to follow and we'll create you a personalised feed. It's like social media, but better. Oh, and we should mention - it's free.

Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc. Pharmaceutical Media Inc.